Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting

Allison J. Hahr; Mark E. Molitch

doi:10.1016/j.disamonth.2009.12.009

Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting

Allison J. Hahr^*, Mark E. Molitch

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Review article

6 Scopus citations

Abstract

Management of type 1 and type 2 diabetes is continually evolving, and among these evolving therapies is administration of insulin in its various forms. The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain.

Original language	English (US)
Pages (from-to)	148-162
Number of pages	15
Journal	Disease-a-Month
Volume	56
Issue number	3
DOIs	https://doi.org/10.1016/j.disamonth.2009.12.009
State	Published - Mar 1 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.disamonth.2009.12.009

Fingerprint Dive into the research topics of 'Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting'. Together they form a unique fingerprint.

Cite this

Hahr, A. J., & Molitch, M. E. (2010). Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting. Disease-a-Month, 56(3), 148-162. https://doi.org/10.1016/j.disamonth.2009.12.009

@article{1e098fdb95ee495daf99d7d0b81aeb90,

title = "Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting",

abstract = "Management of type 1 and type 2 diabetes is continually evolving, and among these evolving therapies is administration of insulin in its various forms. The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain.",

author = "Hahr, {Allison J.} and Molitch, {Mark E.}",

year = "2010",

month = mar,

day = "1",

doi = "10.1016/j.disamonth.2009.12.009",

language = "English (US)",

volume = "56",

pages = "148--162",

journal = "Disease-a-Month",

issn = "0011-5029",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

T2 - Optimal Dosing and Timing in the Outpatient Setting

AU - Hahr, Allison J.

AU - Molitch, Mark E.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Management of type 1 and type 2 diabetes is continually evolving, and among these evolving therapies is administration of insulin in its various forms. The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain.

AB - Management of type 1 and type 2 diabetes is continually evolving, and among these evolving therapies is administration of insulin in its various forms. The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain.

UR - http://www.scopus.com/inward/record.url?scp=77249136410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249136410&partnerID=8YFLogxK

U2 - 10.1016/j.disamonth.2009.12.009

DO - 10.1016/j.disamonth.2009.12.009

M3 - Review article

C2 - 20189500

AN - SCOPUS:77249136410

VL - 56

SP - 148

EP - 162

JO - Disease-a-Month

JF - Disease-a-Month

SN - 0011-5029

IS - 3

ER -